Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.

14/11/2022
/ Publications
/
IMPT
IMRT
Toxicity
Survival

Among the 292 patients with nonmetastatic oropharyngeal cancer of which 272 [93%] were HPV–positive tumors, 58 patients (20%) were treated with IMPT and 234 (80...

Toxicity with proton therapy for oral and/or oropharyngeal cancers: A scoping review.

14/08/2023
/ Publications
/
Toxicity

This review included 18 primary studies for analysis focusing on acute toxicities including dysphagia, radiation dermatitis, oral mucositis, dysgeusia and...

Advances in Proton Therapy for the Management of Head and Neck Tumors.

14/07/2023
/ Publications
/
Toxicity

A review article summarized the advances of PBRT as compared to photon-based RT. Clinical evidence has demonstrated promising results of PBRT in the treatment...

Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience.

14/07/2023
/ Publications
/
Toxicity
IMRT

This is study retrospectively analyzed 311 patients with sinonasal tumors treated with IMRT or PT. With median follow-up of 75 months, this study reported 10...

Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.

14/08/2023
/ Publications
/
Survival
Toxicity

For the 26 patients with salivary gland tumor treated with PBSPT, at a median follow-up time of 46 months, 5 (19%), 2 (8%), 3 (12%) and 2 (8%) patients...

A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer.

14/01/2024
/ Publications
/
Toxicity

Osteoradionecrosis (ORN), which is a serious complication and late toxicity of radiotherapy, has been reported in proton therapy. This meta-analysis included 17...

Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives.

14/02/2021
/ Publications
/
Reirradiation

This review examines the evolving role of PBT in the treatment of thoracic malignancies and evaluates the data supporting its use. Clinical outcomes data of PBT...

Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer.

14/03/2021
/ Publications
/
Toxicity

This study retrospectively reviewed 53 patients who received salvage PBT for locoregionally recurrent NSCLC. With a median follow-up time of 15.0 months, 26...

Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations.

14/02/2021
/ Publications

A review article examined data available of proton radiation for early-stage, advanced-stage and recurrent NSCLC, as well as protons in post-operative...

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.

14/09/2021
/ Publications
/
IMRT
Toxicity

This study retrospectively evaluated 136 postoperative radiotherapy (PORT) patients (61 PBT, 75 IMRT). Median OS was 76 and 46 months for PBT and IMRT with...